Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of preparation method of hepatitis C medicine intermediate

A technology of intermediates and drugs, which is applied in the field of preparation of hepatitis C drug intermediates, can solve the problems of reducing process costs, difficulty in industrialization, and high cost, and achieve the effect of reducing process costs and realizing feasibility

Active Publication Date: 2016-06-08
PORTON PHARMA SOLUTIONS LTD
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0024] Aiming at the high cost and difficult industrialization of the compound represented by formula I of high purity, the present invention improves the previous method, and uses a cheap chemical method to perform a resolution combined with recrystallization under a specific solvent condition. , under the condition that the chemical purity of the product is greater than 99%, and the optical purity is greater than 98%, the process cost is greatly reduced, and the feasibility of industrial production of the compound shown in formula I is realized

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of preparation method of hepatitis C medicine intermediate
  • A kind of preparation method of hepatitis C medicine intermediate
  • A kind of preparation method of hepatitis C medicine intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] The 500ml three-necked flask is equipped with a mechanical stirrer, a thermometer, and a condensation reflux tube. At 45°C, add 38.6g of D-di-p-toluyl tartaric acid (D-DTTA) (0.1mol), 200g of ethanol, 20g of water, stir to dissolve, and dropwise add 15.5g of 1-amino-2-vinylcyclopropanyl formic acid Ethyl ester, a solid is produced during the process. Raise the temperature to reflux to dissolve and clarify, then slowly cool down to 20°C, crystallize, filter with suction, and dry to obtain (1R,2S)-1-amino-2-vinylcyclopropane ethyl carboxylate D-di-p-methylbenzene Formyl tartaric acid (D-DTTA) salt is a white solid, the enantiomeric excess (ee) value is 77.5% and the yield is 38.9%.

[0034] The 500ml three-necked flask is equipped with a mechanical stirrer, a thermometer, and a condensation reflux tube. Add 50g of (1R,2S)-1-amino-2-vinylcyclopropane ethyl carboxylate D-di-p-toluyl tartaric acid (D-DTTA) salt prepared in the previous step, 500g of ethanol, 50g of water, ...

Embodiment 2

[0038] The 500ml three-necked flask is equipped with a mechanical stirrer, a thermometer, and a condensation reflux tube. At 40°C, add 38.6g of D-di-p-toluyl tartaric acid (D-DTTA) (0.1mol), 150g of methanol, 20g of water, stir to dissolve, and dropwise add 15.5g of 1-amino-2-vinylcyclopropanyl formic acid Ethyl ester, a solid is produced during the process. Heat up to reflux to dissolve and clarify, then slowly cool down to 25°C, crystallize, filter with suction, and dry to obtain (1R,2S)-1-amino-2-vinylcyclopropanylcarboxylate D-DTTA salt white solid, The enantiomeric excess (ee) value of the sample sent was 80.7%, and the yield was 37.2%.

[0039] The 500ml three-necked flask is equipped with a mechanical stirrer, a thermometer, and a condensation reflux tube. Add 50g of (1R,2S)-1-amino-2-vinylcyclopropane ethyl carboxylate D-di-p-toluyl tartaric acid (D-DTTA) salt prepared in the previous step, 450g methanol, 60g water, and heat up Dissolve and clarify at reflux, then s...

Embodiment 3

[0042] The 500ml three-necked flask is equipped with a mechanical stirrer, a thermometer, and a condensation reflux tube. At 30°C, add 38.6g D-di-p-toluyl tartaric acid (D-DTTA) (0.1mol), 250g isopropanol, 40g water, stir to dissolve, add dropwise 15.5g 1-amino-2-vinylcyclopropane Ethyl formate, solids are generated during the process. Raise the temperature to reflux to dissolve and clarify, then slowly cool down to 15°C, crystallize, filter with suction, and dry to obtain (1R,2S)-1-amino-2-vinylcyclopropane ethyl carboxylate D-di-p-methylbenzene Formyl tartaric acid (D-DTTA) salt is a white solid, the enantiomeric excess (ee) value is 77.1% and the yield is 40.4%.

[0043] The 500ml three-necked flask is equipped with a mechanical stirrer, a thermometer, and a condensation reflux tube. Add 50g of (1R,2S)-1-amino-2-vinylcyclopropane ethyl carboxylate D-di-p-methylbenzoyl tartaric acid (D-DTTA) salt prepared in the previous step, 600g of isopropanol, 100g of water , heat up ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a method for preparing a drug intermediate for hepatitis c. More specifically, only dihydroxysuccinic acid (D-DTTA) is adopted as a resolving agent to split under a specific condition, and the split crude product is crystallized again under the specific condition, so as to obtain the product with high purity.

Description

technical field [0001] The invention relates to a preparation method of a hepatitis C drug intermediate, more specifically, a high-purity hepatitis C drug intermediate is prepared by a chemical resolution method. Background technique [0002] Hepatitis C virus, referred to as hepatitis C, hepatitis C, is a kind of viral hepatitis caused by hepatitis C virus (Hepatitis C virus, HCV) infection, mainly through blood transfusion, acupuncture, drug abuse, etc., according to the statistics of the World Health Organization , the global hepatitis C virus (HCV) infection rate is about 3%, it is estimated that about 180 million people are infected with global hepatitis C virus (HCV), and there are about 35,000 new cases of hepatitis C every year. Hepatitis C is a global epidemic, which can lead to chronic inflammation, necrosis and fibrosis of the liver, and some patients can develop liver cirrhosis and even hepatocellular carcinoma (HCC). Some data show that the death rate (death ca...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07C227/34C07C229/48
Inventor 王岭郑宏杰彭磊
Owner PORTON PHARMA SOLUTIONS LTD